- Home
- GRABW vs SRPT Comparison
GRABW vs SRPT Comparison
Compare GRABW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- SRPT
- Stock Information
- Founded
- GRABW 2012
- SRPT 1980
- Country
- GRABW Singapore
- SRPT United States
- Employees
- GRABW 11267
- SRPT 1372
- Industry
- GRABW Business Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- SRPT Health Care
- Exchange
- GRABW Nasdaq
- SRPT Nasdaq
- Market Cap
- GRABW N/A
- SRPT 1.7B
- IPO Year
- GRABW N/A
- SRPT 1997
- Fundamental
- Price
- GRABW N/A
- SRPT $18.19
- Analyst Decision
- GRABW
- SRPT Buy
- Analyst Count
- GRABW 0
- SRPT 25
- Target Price
- GRABW N/A
- SRPT $64.00
- AVG Volume (30 Days)
- GRABW 54.7K
- SRPT 7.9M
- Earning Date
- GRABW 02-21-2025
- SRPT 08-06-2025
- Dividend Yield
- GRABW N/A
- SRPT N/A
- EPS Growth
- GRABW N/A
- SRPT N/A
- EPS
- GRABW N/A
- SRPT N/A
- Revenue
- GRABW $2,686,000,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- GRABW N/A
- SRPT $26.87
- Revenue Next Year
- GRABW N/A
- SRPT $3.15
- P/E Ratio
- GRABW N/A
- SRPT N/A
- Revenue Growth
- GRABW 21.65
- SRPT 59.15
- 52 Week Low
- GRABW $0.15
- SRPT $16.88
- 52 Week High
- GRABW $0.59
- SRPT $155.95
- Technical
- Relative Strength Index (RSI)
- GRABW 53.67
- SRPT 23.09
- Support Level
- GRABW $0.33
- SRPT $16.88
- Resistance Level
- GRABW $0.40
- SRPT $18.62
- Average True Range (ATR)
- GRABW 0.02
- SRPT 1.40
- MACD
- GRABW 0.00
- SRPT 0.09
- Stochastic Oscillator
- GRABW 94.29
- SRPT 6.41
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.